Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by dennis001 – Hong Kong, 2022-07-27 07:21 (1418 d 11:11 ago) – Posting: # 23181
Views: 6,126

Dear ElMaestro
Thanks!

❝ Clearly a case for an NI trial one way or another.


Thank you for your comment that helped to assuage my doubts.

❝ Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.


Ok. we will discuss with them.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
138 visitors (0 registered, 138 guests [including 25 identified bots]).
Forum time: 18:33 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5